Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties

Apoptosis

Volumn 8, Issue 4, 2003, Pages 345-352

  Caserta, T M ^a   Smith, A N ^a   Gultice, A D ^a   Reedy, M A ^a   Brown, T L ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Caspase; Inhibitors

Indexed keywords

AMINO ACID; APOPTOSIS INHIBITOR; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BUTYLOXYCARBONYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE 10; CASPASE 12; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; QUINOLYLVALYLMETHOXYASPARTYL(2,6 DIFLUOROPHENOXY)METHYL KETONE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; BENZYL COMPOUNDS; CASPASES; CYSTEINE PROTEINASE INHIBITORS; DACTINOMYCIN; DNA FRAGMENTATION; HUMANS; HYDROCARBONS, FLUORINATED; JURKAT CELLS; MICE; NUCLEIC ACID SYNTHESIS INHIBITORS; QUINOLINES; RATS; THAPSIGARGIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0041666539     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024116916932     Document Type: Article

References (25)

1. Plas DR, Thompson CB. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metab 2002; 13: 75-78.
2. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-424.
3. Salvesen GS, Dixit VM. Caspases: Intracellular signaling by proteolysis. Cell 1997; 91: 443-446.
4. Cohen GM. Caspases: The executioners of apoptosis. Biochem J 1997; 326: 1-16.
5. Brown TL, Patil S, Howe PH. Analysis of TGFβ-inducible apoptosis. In: Howe P, ed. Methods in Molecular Biology - "Transforming Growth Factor-Beta Protocols." Vol. 142. Totowa, NJ: Humana Press 2000; 149-167
6. Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol 2000; 2: 156-162.
7. Yin XM. Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res 2000; 10: 161-167.
8. Fujino M, Li XK, Kitazawa Y, Guo L, Kawasaki M, Funeshima N, Amano T, Suzuki S. Distinct pathways of apoptosis triggered by FTY720, etoposide, and anti-Fas antibody in human T-lymphoma cell line (Jurkat cells). J Pharmacol Exp Ther 2002; 300: 939-945.
9. Robertson JD, Enoksson M, Suomela M, Zhivotovsky B, Orrenius S. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 2002; 277: 29803-29809.
10. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000; 403: 98-103.
11. Rao RV, Hermel E, Castro-Obregon S, del Rio G, Ellerby LM, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem 2001; 276: 33869-33874.
12. Fischer H, Koenig U, Eckhart L, Tschachler E. Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun. 2002; 293(2): 722-726.
13. Schotte P, Declercq W, Van Huffel S, Vandenabeele P, Beyaert R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett 1999; 442: 117-121.
14. Van Noorden CJ. The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition. Acta Histochem 2001; 103: 241-251.
15. Brown TL, Patil S, Basnett RK, Howe PH. Caspase inhibitor BD-fmk distinguishes transforming growth factor b-induced apoptosis from growth inhibition. Cell Growth Diff 1998; 9: 869-875.
16. Brown TL, Patil S, Cianci CD, Morrow JS, Howe PH. TGF beta induces caspase 3 independent cleavage of alpha II spectrin (alpha-fodrin) coincident with apoptosis. J Biol Chem 1999; 274: 23256-23262.
17. Mischak R. Apoptosis. ICN/ESP Caspase inhibitors: Applications in vivo and in vitro. ICN Bioconcepts 2002; 8: 1-5.
18. Patil S, Wildey GM, Brown TL, Choy L, Derynck R, Howe PH. Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-beta - induced growth inhibition and apoptosis. J Biol Chem 2000; 275: 38363-38370.
19. Fischer G, Kent SC, Joseph L, Green DR, Scott DW. Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of Myc. J Exp Med 1994; 179: 221-228.
20. Warner GL, Ludlow JW, Nelson DA, Gaur A, Scott DW. Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent. Cell Growth Diff 1992; 3: 175-181.
21. Wu M, Bellas RE, Shen J, Yang W, Sonenshein GE. Increased p27Kip1 cyclin dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells. J Immunol 1999; 163: 6530-6535.
22. Wu M, Arsura M, Bellas RE, FitzGerald MJ, Lee H, Schauer SL, Sherr DH, Sonenshein GE. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol Cell Biol 1996; 16: 5015-5025.
23. Lee JR, Koretzky GA. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line. J Immunol 1998; 161: 1637-1644.
24. Fang W, Rivard JJ, Ganser JA, LeBien TW, Nath KA, Mueller DL, Behrens TW. Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J Immunol 1995; 155: 66-75.
25. Chen L, Kim TJ, Pillai S. Inhibition of caspase activity prevents anti-IgM induced apoptosis but not ceramide generation in WEHI 231 B cells. Mol Immunol 1998; 35: 195-205.